1. Gemcitabine and cisplatin induction chemotherapy in nasopharyngeal carcinoma;Zhang;N Engl J Med,2019
2. Metronomic capecitabine as adjuvant therapy in locoregionally advanced nasopharyngeal carcinoma: A multicentre, open-label, parallel-group, randomised, controlled, phase 3 trial;Chen;Lancet,2021
3. Exploratory study of NPC-0501 trial: Optimal cisplatin dose of concurrent and induction/adjuvant chemotherapy for locoregionally advanced nasopharyngeal carcinoma;Ng;Clin Cancer Res,2022
4. Network-meta-analysis of chemotherapy in nasopharyngeal carcinoma (MAC-NPC): An update on 8, 221 patients;Petit;J Clin Oncol,2020
5. Final overall survival analysis of gemcitabine and cisplatin induction chemotherapy in nasopharyngeal carcinoma: A multicenter, randomized phase III trial;Zhang;J Clin Oncol,2022